摘要
食管胃静脉曲张出血是肝硬化的主要并发症之一，也是肝硬化失代偿期患者的主要死亡原因之一。特利加压素系三甘氨酰-赖氨酸血管加压素，是一种人工合成的血管加压素类似物，主要用于治疗急性静脉曲张破裂出血。现从循证医学角度回顾特利加压素治疗食管胃静脉曲张出血的当前现状。
Gastroesophageal variceal bleeding is one of the major complications of cirrhosis and also the leading causes of death in patients with decompensated cirrhosis. Terlipressin is a triglycyllysine vasopressin, a synthetic vasopressin analogue that is mainly used for the treatment of acute variceal hemorrhage. This article aims to review the current status of treatment of gastroesophageal variceal bleeding with terlipressin from the perspective of evidence-based medicine.
作者
周新苗
祁兴顺
贾继东
Zhou Xinmiao;Qi Xingshun;Jia Jidong(Graduate School, Jinzhou Medical University, Jinzhou 121000, China;Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110840, Chin;Center for Liver Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, Chin)
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2018年第4期245-248,共4页
Chinese Journal of Hepatology
关键词
肝硬化
静脉曲张
临床试验
Liver cirrhosis
Varicose veins
Clinical trial
